BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Facet Solutions, Inc. Completes 1 Year Follow-up on U.S. Pilot Study


4/23/2009 11:25:27 AM

HOPKINTON, Mass., April 23 /PRNewswire/ -- Facet Solutions, Inc. today announced the publication of its one-year data for the ACADIA(TM) U.S. Pilot Clinical Study. The study utilized the ACADIA(TM) Facet Replacement System for the treatment of lumbar spinal stenosis. The results showed dramatic improvements across all measures, including an 88% reduction in Oswestry Disability Index, a 77% reduction in back pain, and an 83% reduction in leg pain. There were no device-related adverse events in any of the patients.

"The results continue to be impressive," commented Dr. John Regan (St. John's Hospital, Santa Monica, CA), who is the principal investigator for the ACADIA(TM) stenosis study. "Facet replacement surgery will offer stenosis patients who currently undergo lumbar fusion a compelling motion preservation option to address both pain and function."

Facet Solutions' President & CEO Geoff Pardo added, "These results have exceeded our expectations and provide us with further confidence that this important technology will provide significant patient benefits. Patients and surgeons tell us they want a lumbar spine solution which provides pain relief and anatomic motion, and we think we have that solution." Facet Solutions, Inc. is currently enrolling patients in its Multi-center Pivotal Study in the United States.

One year data from Facet Solutions' U.S. Pilot Study will be presented at the upcoming Spine Arthroplasty Society meeting (SAS9) to be held April 27th-May 1st, 2009 in London, England.

*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners DeNovo Ventures, FirstMark Capital, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.

CONTACT: Mr. Geoff Pardo, President & CEO of Facet Solutions, Inc.,
+1-617-407-4865, geoff@facetsolutions.com

Web site: http://www.facetsolutions.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES